Trial Profile
A randomized, open-label study of the effect of 2 different treatment schedules of Xeloda with Eloxatin and Avastin on progression-free survival in treatment-naïve patients with locally advanced or metastatic colorectal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2014
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms XELOX-A-DVS
- Sponsors Roche
- 20 Oct 2006 New trial record.